First Citizens Bank & Trust’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$699K Sell
8,929
-159
-2% -$10.8K 0.01% 385
2026
Q1
$587K Buy
9,088
+175
+2% +$12.3K 0.01% 405
2025
Q4
$600K Buy
8,913
+242
+3% +$16.3K 0.01% 404
2025
Q3
$636K Buy
8,671
+281
+3% +$18.7K 0.01% 387
2025
Q2
$436K Buy
+8,390
New +$477K 0.01% 462
2025
Q1
– Sell
-4,704
Closed -$225K – 526
2024
Q4
$225K Buy
4,704
+681
+17% +$34.9K ﹤0.01% 436
2024
Q3
$230K Buy
+4,023
New +$231K 0.01% 423

Other funds holding HALO

First Citizens Bank & Trust's HALO Position: Q2 2026 in Review

First Citizens Bank & Trust reduced its Halozyme (HALO) stake by 1.7% in Q2 2026, selling an estimated $10.8K and leaving 8,929 shares worth $699K. The position accounts for 0.01% of the portfolio, ranked #385.

First Citizens Bank & Trust first reported a position in HALO in Q3 2024 and has held it in 7 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • First Citizens Bank & Trust held 8,929 shares of Halozyme worth $699K as of Q2 2026.
  • First Citizens Bank & Trust sold 159 Halozyme shares in Q2 2026, an estimated $10.8K.
  • Halozyme made up 0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #385 holding.
  • First Citizens Bank & Trust first reported a position in Halozyme in Q3 2024 and has held it in 7 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.